<ARTICLE> 5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company for the period ended 9/30/98 </LEGEND> <MULTIPLIER> 1000000 <PERIOD-TYPE> 9-Mos <FISCAL-YEAR-END> Dec-31-1998 <F1> <PERIOD-END> Sep-30-1998 <CASH> 1531 <SECURITIES> 308 <RECEIVABLES> 3129 <F2> <ALLOWANCES> 0 <INVENTORY> 1775 <CURRENT-ASSETS> 7720 <PP&E> 7221 <DEPRECIATION> 2973 <TOTAL-ASSETS> 14925 <CURRENT-LIABILITIES> 4645 <BONDS> 1314 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 109 <OTHER-SE> 7438 <TOTAL-LIABILITY-AND-EQUITY> 14925 <SALES> 13399 <TOTAL-REVENUES> 13399 <CGS> 3549 <TOTAL-COSTS> 3549 <OTHER-EXPENSES> 2932 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 113 <INCOME-PRETAX> 3802 <INCOME-TAX> 1074 <INCOME-CONTINUING> 2728 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2728 <EPS-PRIMARY> 2.74 <EPS-DILUTED> 2.68 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.